MAPS bulletin - volume xvii - number 1 - spring/summer 2007 - "The Chrysalis Stage"

	Rick Doblin, MAPS founder and President, earned his Ph.D. in Public Policy from the Kennedy School of Government at Harvard University. Doblin was also in Stan and Christina Grof’s first training group to receive certification as a Holotropic Breathwork practitioner.

	Valerie Mojeiko, Director of Operations and Clinical Research Associate, studied psychology with an emphasis on drug addiction and psychedelic therapy for four years at New College of Florida. Currently, she provides data monitoring services for MAPS-sponsored research and coordinates other projects.

	Josh Sonstroem, Technology Specialist and Events Coordinator, earned his B.A. in Philosophy and Religion from New College of Florida and is a chef, musician, poet, technologist, and masseuse. He immensely enjoys the depths of existential experience.

	Jag Davies, Director of Communications, has a B.A. in cultural anthropolgy and enjoys examining the intersections of drug policy, media, culture and consciousness. He has been working at MAPS since 2003, where he coordinates outreach projects, research advocacy, and educational materials, including the MAPS Bulletin, monthly email news, and website content.

	Sarah Hufford, Membership and Sales Manager, joined the MAPS staff in the Fall of 2005, after receiving her bachelor’s degree in psychology from New College of Florida. She values psychedelics and marijuana as powerful medicines, and hopes to help integrate their safe and conscientious use into our society.

	Troy Dayton, MAPS Director of Development has worked in the drug policy reform movement for over 12 years. He is committed to removing coercion from society and views the Drug War as the most insidious example of government force. Troy’s mission is to help people who agree with drug policy reform find their individual capacity to make a difference.

MAPS bulletin - volume xvii - number 1 - spring/summer 2007

< Return to Bulletin Archive Index

MAPS: Who We Are

MAPS IS A MEMBERSHIP-BASED ORGANIZATION working to assist researchers worldwide to design, fund, conduct, obtain governmental approval for, and report on psychedelic research in humans. Founded in 1986, MAPS is an IRS approved 501 (c)(3) non-profit corporation funded by taxdeductible donations from members.

MAPS has previously funded basic scientific research in both humans and animals into the safety of MDMA (3,4- methylene-dioxymethamphetamine, Ecstasy) and has opened a Drug Master File for MDMA at the U.S. Food and Drug Administration. MAPS is now primarily focused on assisting scientists to conduct human studies to generate essential information about the risks and therapeutic benefits of MDMA, other psychedelics, and marijuana, with the goal of eventually gaining governmental approval for their medical uses.

Albert Einstein Wrote:
“Imagination is more important
than knowledge.”

If you can even faintly imagine a cultural reintegration of the use of psychedelics and the states of mind they engender, please join MAPS in supporting the expansion of scientific knowledge in this area. Progress is possible with the support of those who care enough to take individual and collective action.

THE MAPS BULLETIN

Each Bulletin reports on MAPS research in progress. In addition to reporting on research both in the United States and abroad, the Bulletin may include feature articles, reports on conferences, book reviews, Heffter Research Institute updates, and the Hofmann Report. Issues raised in letters, calls, and e-mail from MAPS members may also be addressed, as may political developments that affect psychedelic research and use.

© 2007 Multidisciplinary Association for Psychedelic Studies, Inc. (MAPS)
10424 Love Creek Road,
Ben Lomond, CA 95005
Phone: 831-336-4325
Fax: 831-336-3665
E-mail: askmaps@maps.org
Web: www.maps.org

< Return to Table of Contents: - Spring/Summer 2007 "The Chrysalis Stage"

Spring 2010	Vol. 20, No. 1	Special Edition: Psychedelics, Death and Dying
Autumn 2009	Vol. 19, No. 3	MAPS Financial Report: Fiscal Year 2008-09
Summer 2009	Vol. 19, No. 2	MAPS Research Update 2009
Spring 2009	Vol. 19, No. 1	Special Edition: Psychedelics and Ecology
Winter 2008/09	Vol. 18, No. 3	MAPS 2008 Financial Report
Summer 2008	Vol. 18, No. 2	Phoenix Rising: A Review of MAPS Research
Spring 2008	Vol. 18, No. 1	Special Edition: Technology and Psychedelics
Winter 2007	Vol. 17, No. 3	MAPS 06-07 Fiscal Yearly Report
Autumn 2007	Vol. 17, No. 2	Special Edition: Psychedelics and Self-Discovery
Spring/Summer 2007	Vol. 17, No. 1	The Chrysalis Stage
Winter 2006-7	Vol. 16, No. 3	Low Maintenance/High Performance
Autumn 2006	Vol. 16, No. 2	Technologies of Healing
Spring 2006	Vol. 16, No. 1	MAPS' 20th Anniversary
Winter 2005	Vol. 15, No. 3	MAPS final year as a teenager
Summer 2005	Vol. 15, No. 2	Israel Conference: MDMA/PTSD Research
Spring 2005	Vol. 15, No. 1	Accelerating flow of work and time
Autumn 2004	Vol. 14, No. 2	Rites of Passage: Kids and Psychedelics
Summer 2004	Vol. 14, No. 1	10 stamps and $250,000
Winter 2003	Vol. 13, No. 2	Holy Fire
Spring 2003	Vol. 13, No. 1	60th Anniversary of the Discovery of LSD
Autumn 2002	Vol. 12, No. 3	Vision
Summer 2002	Vol. 12, No. 2	"From celebration to frustration, and back again."
Spring 2002	Vol. 12, No. 1	Sex, Spirit & Psychedelics 2002
Autumn 2001	Vol. 11, No. 2	"In the future, it will be called Despair."
Spring 2001	Vol. 11, No. 1	"A Tidal Wave of Ecstasy!"
Autumn 2000	Vol. 10, No. 3	Creativity 2000
Summer 2000	Vol. 10, No. 2	Endings and Beginnings
Spring 2000	Vol. 10, No. 1	Making History in Slow Motion
Winter 1999/00	Vol. 9, No. 4	To the Ends of the Earth for MDMA Research...
Autumn 1999	Vol. 9, No. 3	MAPS' long-standing efforts to conduct...
Summer 1999	Vol. 9, No. 2	MAPS has come full circle...
Spring 1999	Vol. 9, No. 1	Patience, persistence and passion
Winter 1998/99	Vol. 8, No. 4	One of special pleasures of directing MAPS...
Autumn 1998	Vol. 8, No. 3	The Ayahuasca Issue (with Hofmann interview)
Summer 1998	Vol. 8, No. 2	Emotionally Powerful Anecdotes...
Spring 1998	Vol. 8, No. 1	Death Has a Way of Focusing One's Attention
Autumn 1997	Vol. 7, No. 4	Celebration is in Order
Summer 1997	Vol. 7, No. 3	Time Horizons
Spring 1997	Vol. 7, No. 2	Synchronicity
Winter 1996/97	Vol. 7, No. 1	Learning to Crawl
Autumn 1996	Vol. 6, No. 4	An Invitation for Dialogue
Summer 1996	Vol. 6, No. 3	Budding Research
New Year 1996	Vol. 6, No. 2	Sending Down Roots
Autumn 1995	Vol. 6, No. 1	Baby Steps
Summer 1995	Vol. 5, No. 4	Opportunity Amidst Obstacles
Winter 1994/95	Vol. 5, No. 3	Clinical Trials and Tribulations
Autumn 1994	Vol. 5, No. 2	Building Towards Clinical Trials
Summer 1994	Vol. 5, No. 1	Politics and Protocols: In Search of a Balance
Spring 1994	Vol. 4, No. 4	Laying the Groundwork
Winter 1993/94	Vol. 4, No. 3	A Time of Tests
Summer 1993	Vol. 4, No. 2	So Close Yet So Far
Spring 1993	Vol. 4, No. 1	Remembrance and Renewal
Winter 1992/93	Vol. 3, No. 4	Forging New Alliances
Summer 1992	Vol. 3, No. 3	Building on Common Ground
Spring 1992	Vol. 3, No. 2	Small Steps, Gradual Progress, New Opportunities
Winter 1991/92	Vol. 3, No. 1	The Rekindling of a Thousand Points of Light
Summer 1991	Vol. 2, No. 2	MDMA protocol development with cancer patients
Winter 1990/91	Vol. 2, No. 1	MAPS' Swiss pharmacologically-assisted psychotherapy conference
Autumn 1990	Vol. 1, No. 3	What and Who is MAPS?
Summer 1989	Vol. 1, No. 2	Switzerland Leads the Way
Summer 1988	Vol. 1, No. 1	MDMA can become a legal medicine